Sandmann S, Unger T L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil Journal of Clinical and Basic Cardiology 1999; 2 (2): 187-201 PDF Summary Overview | ||||||||||||||||||
Figure/Graphic 12: Kalziumkanal - Mibefradil Left panel: Maximal ST-segment depression in mV before (open bars) and 2 hours after (hatched bars) intake of placebo or 50, 100, or 200 mg/kg mibefradil; * p < 0.05. Right panel: Mean exercise duration in minutes before (open bars) and 2 hours after (hatched bars) intake of placebo or 50, 100, or 200 mg/kg mibefradil; * p < 0.05. |
Figure/Graphic 12: Kalziumkanal - Mibefradil
Left panel: Maximal ST-segment depression in mV before (open bars) and 2 hours after (hatched bars) intake of placebo or 50, 100, or 200 mg/kg mibefradil; * p < 0.05. Right panel: Mean exercise duration in minutes before (open bars) and 2 hours after (hatched bars) intake of placebo or 50, 100, or 200 mg/kg mibefradil; * p < 0.05. |
